Search results
Results from the WOW.Com Content Network
Ubhejane (sometimes stylized as uBhejane, Zulu for "black rhinoceros") [1] is a South African herbal medicine marketed as a treatment for HIV/AIDS, reportedly the most popular alternative medicine treatment for the disease in South Africa. [1] It was invented by former truck driver Zeblon Gwala, who has claimed that he got the idea for it in a ...
Well-known contributions to world medicine from South African herbal remedies include aloe, buchu and devil's claw. [76] Public health specialists are now enlisting sangomas in the fight, not only against the spread of HIV/AIDS, but also diarrhoea and pneumonia, which are major causes of death in rural areas, especially in children. [7] [77]
During the HIV/AIDS epidemic traditional healers' methods were criticised by practitioners of modern medicine, and in particular the use of certain herbal treatments for HIV/AIDS. According to Edward Mills, herbal remedies are used as a therapy for HIV-symptoms such as "dermatological disorders, nausea, depression, insomnia, and weakness."
The leaves are used as herbal medicine to alleviate cough and fever, pain, and general gastrointestinal disorders as well as to cure dermatologic disorders. Similarly, the fruit juice and oils can be used in the treatment of liver disease, gastrointestinal disorders, chronic wounds or other dermatological disorders.
In the early 1980s, AIDS had newly been recognized as a disease as an epidemic started in the United States, with numerous cases in New York and other major cities. Bowman claimed that HIV is not the cause of AIDS and used herbal remedies to treat people. [17]
Some herbs may amplify the effects of anticoagulants. [51] Certain herbs as well as common fruit interfere with cytochrome P450, an enzyme critical to much drug metabolism. [52] In a 2018 study, the FDA identified active pharmaceutical additives in over 700 analyzed dietary supplements sold as "herbal", "natural" or "traditional". [53]
This is the first trial showing the effects of semaglutide in HIV patients with a type of liver disease known as Metabolic dysfunction-associated steatotic liver disease (MASLD).
A number of "entry-inhibiting" or "entry-blocking" drugs are being developed to fight HIV. HIV most heavily targets a specific type of lymphocyte known as "helper T cells", and identifies these target cells through T-cell surface receptors designated "CD4" and "CCR5". Attempts to interfere with the binding of HIV with the CD4 receptor have ...